CIBC Private Wealth Group
DGX icon

CIBC Private Wealth Group’s Quest Diagnostics DGX Stock Holding History

CIBC Private Wealth Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$699K Sell
4,028
-507
-11% -$92.3K ﹤0.01% 780
2025
Q3 		$864K Buy
4,535
+283
+7% +$50.2K ﹤0.01% 730
2025
Q2 		$764K Buy
4,252
+461
+12% +$80.1K ﹤0.01% 719
2025
Q1 		$606K Buy
3,791
+557
+17% +$91.5K ﹤0.01% 756
2024
Q4 		$498K Buy
3,234
+31
+1% +$4.82K ﹤0.01% 859
2024
Q3 		$497K Sell
3,203
-2,533
-44% -$378K ﹤0.01% 877
2024
Q2 		$797K Sell
5,736
-2,397
-29% -$328K ﹤0.01% 711
2024
Q1 		$1.1M Buy
8,133
+674
+9% +$87.4K ﹤0.01% 650
2023
Q4 		$1.03M Buy
7,459
+4,163
+126% +$547K ﹤0.01% 625
2023
Q3 		$402K Buy
+3,296
New +$439K ﹤0.01% 809
2022
Q2 		– Sell
-3,539
Closed -$484K – 1218
2022
Q1 		$484K Sell
3,539
-958
-21% -$134K ﹤0.01% 756
2021
Q4 		$778K Buy
+4,497
New +$684K ﹤0.01% 693
2021
Q3 		– Sell
-5,922
Closed -$781K – 953
2021
Q2 		$781K Sell
5,922
-235
-4% -$30.8K ﹤0.01% 715
2021
Q1 		$790K Sell
6,157
-165
-3% -$20.3K ﹤0.01% 713
2020
Q4 		$754K Sell
6,322
-1,347
-18% -$164K ﹤0.01% 688
2020
Q3 		$874K Buy
+7,669
New +$906K ﹤0.01% 579
2020
Q2 		– Sell
-8,879
Closed -$713K – 641
2020
Q1 		$713K Buy
+8,879
New +$919K ﹤0.01% 562
2018
Q3 		– Sell
-559
Closed -$61K – 1134
2018
Q2 		$61K Sell
559
-121
-18% -$12.6K ﹤0.01% 1125
2018
Q1 		$68K Buy
680
+441
+185% +$45.2K ﹤0.01% 1091
2017
Q4 		$24K Buy
+239
New +$22.7K ﹤0.01% 1365

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIBC Private Wealth Group's DGX Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Quest Diagnostics (DGX) stake by 11% in Q4 2025, selling an estimated $92.3K and leaving 4,028 shares worth $699K. The position accounts for ﹤0.01% of the portfolio, ranked #780.

CIBC Private Wealth Group first reported a position in DGX in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.1M in Q1 2024. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • CIBC Private Wealth Group held 4,028 shares of Quest Diagnostics worth $699K as of Q4 2025.
  • CIBC Private Wealth Group sold 507 Quest Diagnostics shares in Q4 2025, an estimated $92.3K.
  • Quest Diagnostics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #780 holding.
  • CIBC Private Wealth Group first reported a position in Quest Diagnostics in Q4 2017 and has held it in 20 quarters since.
  • CIBC Private Wealth Group's Quest Diagnostics position peaked at $1.1M in Q1 2024.
  • 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.